Enliven Therapeutics, Inc. (ELVN) - Quarterly Income Statement

Home
ELVN
Financials

19.14 (USD) • At close June 2, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1
Revenue Numbers are in millions	0	0	0	0	0	0.44	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0.08	0	0.079	0.079	0.077	0.079	0.074	0.067	0	0.104	0.495	0.025	0.025	0.024	0.025	0.025	0	0	0	0	0	0	0	0
Gross Profit Numbers are in millions	0	0	0	-0.079	-0.079	0.363	-0.079	-0.074	-0.067	0	-0.104	-0.495	-0.025	-0.025	-0.024	-0.025	-0.025	0	0	0	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0	0.825	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	24.895	20.724	21.258	18.826	19.891	17.828	19.606	15.183	11.88	0.18	7.829	7.937	7.059	6.864	10.397	10.074	7.115	8.959	9.533	7.869	5.793	5.942	5.141	4.366	3.56
General & Administrative Expenses Numbers are in millions	6.798	6.172	5.81	5.777	6.017	4.824	4.642	4.951	4.538	1.966	3.105	1.079	1.619	1.531	3.262	3.095	3.165	2.591	2.961	2.433	1.559	1.541	1.741	1.191	0.634
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	0	0	0	0	3.075	0	0	0	0	-0.024	-0.025	-0.025	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	6.798	6.172	5.81	5.777	6.017	4.824	4.642	4.951	4.538	3.077	3.105	1.079	1.619	1.531	3.238	3.07	3.14	2.591	2.961	2.433	1.559	1.541	1.741	1.191	0.634
Other Expenses Numbers are in millions	0	0	0	0	-0.001	-0.009	-0.013	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Expenses Numbers are in millions	31.693	26.816	27.068	24.603	25.908	22.652	24.248	20.134	16.418	3.257	10.934	9.016	8.678	8.395	13.635	13.144	10.255	11.55	12.494	10.302	7.352	7.483	6.882	5.557	4.194
Operating Income Numbers are in millions	-31.693	-26.896	-27.068	-24.603	-25.987	-22.729	-24.248	-20.134	-16.418	-3.257	-10.934	-9.016	-8.678	-8.395	-13.659	-13.169	-10.28	-11.55	-12.494	-10.302	-7.352	-7.483	-6.882	-5.557	-4.194
Operating Income Ratio Numbers are in millions	0	0	0	0	0	-51.657	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	3.149	3.716	3.912	4.885	3.249	3.359	3.479	3.413	1.694	0.613	0.38	0.127	0.009	0.003	0.012	0.008	0.023	0.032	0.071	0.098	0.137	0.233	0.26	0.16	0
Income Before Tax Numbers are in millions	-28.544	-23.18	-23.156	-19.718	-22.738	-19.37	-20.769	-16.721	-14.724	32.273	-10.554	-8.889	-8.669	-8.392	-13.647	-13.161	-10.257	-11.518	-12.423	-10.204	-7.215	-7.25	-6.622	-5.397	-4.194
Income Before Tax Ratio Numbers are in millions	0	0	0	0	0	-44.023	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	-0.5	0	0.232	0.036	5.186	-3.492	-0.048	-1.694	0.088	0.242	-0.443	0.014	0.008	0.012	0.008	0.023	0.032	0.071	0.098	0.137	0.233	0.26	0.119	-0.04
Net Income Numbers are in millions	-28.544	-23.18	-23.156	-19.95	-22.738	-19.37	-20.769	-16.721	-13.03	32.185	-10.554	-8.889	-8.669	-8.392	-13.647	-13.161	-10.257	-11.518	-12.423	-10.204	-7.215	-7.25	-6.622	-5.397	-4.194
Net Income Ratio Numbers are in millions	0	0	0	0	0	-44.023	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.57	-0.46	-0.48	-0.415	-0.541	-0.471	-0.506	-0.408	-0.795	4.897	-0.701	-1.742	-2.228	-2.179	-2.192	-2.972	-2.334	-2.625	-2.864	-2.374	-3.637	-1.68	-1.533	-1.25	-0.97
EPS Diluted Numbers are in millions	-0.57	-0.46	-0.48	-0.415	-0.541	-0.471	-0.506	-0.408	-0.795	4.897	-0.701	-1.742	-2.228	-2.179	-2.192	-2.972	-2.334	-2.625	-2.864	-2.374	-3.637	-1.68	-1.533	-1.25	-0.97
EBITDA Numbers are in millions	-31.693	-26.816	-26.988	-24.525	-25.908	-22.651	-24.17	-20.06	-16.351	-10.099	-10.874	-8.964	-8.639	-8.362	-13.623	-13.136	-10.232	-11.495	-12.398	-10.179	-7.191	-7.225	-6.614	-5.397	-4.194
EBITDA Ratio Numbers are in millions	0	0	0	0	0	-51.48	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Enliven Therapeutics, Inc.

NASDAQ:ELVN Add to watchlist

NASDAQ:ELVN